Bill dossier · state as of the snapshot
SB 1023: Injectable PrEP: reimbursement through the outpatient prescription-drug benefit
Bill
SB 1023 (2025-2026)
Internal identity
CA|2025-2026|SB1023
Author
Senate author of record
Lifecycle
ENROLLED AND PRESENTED TO GOVERNOR · 30 AUGUST · 6:00 PM
Where it sits
Governor
Last recorded action
August 30, 2026
Recorded vote
—
Enrollment
ENROLLED
Governor
PRESENTED 30 AUGUST 2026, 6:00 PM
Urgency
None recorded
Chapter
Not applicable
Verification
VERIFIED
Governor deadline
September 30, 2026
Verified
September 1, 2026
Latest recorded action
August 30, 2026. Enrolled and presented to the Governor at 6:00 PM.
What the bill does
Would require plans that already cover injectable HIV pre-exposure prophylaxis to offer reimbursement through the outpatient prescription-drug benefit, addressing buy-and-bill barriers for community clinics and smaller practices.
What it does not do
Not law. Presentment starts the gubernatorial clock; it creates no plan obligation. Injectable PrEP coverage nominally exists today — what the bill would change is the reimbursement pathway.
KPSGILL position
No position taken. The clearest current illustration of a distinction the Policy Lab draws repeatedly: coverage does not equal practical access when reimbursement mechanics make a covered treatment financially difficult for a community provider to deliver.
What happens next
Governor action deadline: September 30, 2026, computed from this bill’s own presentment rather than applied mechanically. Every qualifying measure is tracked on the Governor’s Health Bill Desk; scheduled dates sit on the decision calendar.
Primary sources
Register: data/ca-bills.json · internal identity CA|2025-2026|SB1023 · verification state VERIFIED · tracker: California Legislature 2026.